261 related articles for article (PubMed ID: 15106184)
41. Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B.
Liang N; Kong Z; Ma SS; Lu CL; Yang M; Feng LD; Shen C; Diao RH; Cui LJ; Lu XY; Nikolova D; Jakobsen JC; Gluud C; Liu JP
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD013089. PubMed ID: 30941748
[TBL] [Abstract][Full Text] [Related]
42. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
Myers RP; Poynard T
Cochrane Database Syst Rev; 2002; (4):CD003617. PubMed ID: 12519606
[TBL] [Abstract][Full Text] [Related]
43. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
44. Vitamin D supplementation for chronic liver diseases in adults.
Bjelakovic G; Nikolova D; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011564. PubMed ID: 29099543
[TBL] [Abstract][Full Text] [Related]
45. Glucocorticosteroids for primary biliary cirrhosis.
Prince M; Christensen E; Gluud C
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD003778. PubMed ID: 15846681
[TBL] [Abstract][Full Text] [Related]
46. Bile acids for viral hepatitis.
Chen W; Liu J; Gluud C
Cochrane Database Syst Rev; 2003; (2):CD003181. PubMed ID: 12804455
[TBL] [Abstract][Full Text] [Related]
47. Vitamin D supplementation for chronic liver diseases in adults.
Bjelakovic M; Nikolova D; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD011564. PubMed ID: 34431511
[TBL] [Abstract][Full Text] [Related]
48. Phyllanthus species for chronic hepatitis B virus infection.
Xia Y; Luo H; Liu JP; Gluud C
Cochrane Database Syst Rev; 2011 Apr; (4):CD008960. PubMed ID: 21491412
[TBL] [Abstract][Full Text] [Related]
49. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.
Shepherd J; Brodin H; Cave C; Waugh N; Price A; Gabbay J
Health Technol Assess; 2004 Oct; 8(39):iii-iv, 1-125. PubMed ID: 15461877
[TBL] [Abstract][Full Text] [Related]
50. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Abdel-Rahman O; Elsayed Z
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011313. PubMed ID: 31978267
[TBL] [Abstract][Full Text] [Related]
51. Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.
Cummings KJ; Lee SM; West ES; Cid-Ruzafa J; Fein SG; Aoki Y; Sulkowski MS; Goodman SN
JAMA; 2001 Jan; 285(2):193-9. PubMed ID: 11176813
[TBL] [Abstract][Full Text] [Related]
52. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Goh ET; Stokes CS; Sidhu SS; Vilstrup H; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2018 May; 5(5):CD012410. PubMed ID: 29762873
[TBL] [Abstract][Full Text] [Related]
53. Antiviral therapy for recurrent liver graft infection with hepatitis C virus.
Gurusamy KS; Tsochatzis E; Xirouchakis E; Burroughs AK; Davidson BR
Cochrane Database Syst Rev; 2010 Jan; (1):CD006803. PubMed ID: 20091608
[TBL] [Abstract][Full Text] [Related]
54. Ursodeoxycholic acid for primary biliary cirrhosis.
Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD000551. PubMed ID: 23235576
[TBL] [Abstract][Full Text] [Related]
55. Interferon for acute hepatitis C.
Poynard T; Regimbeau C; Myers RP; Thevenot T; Leroy V; Mathurin P; Opolon P; Zarski JP
Cochrane Database Syst Rev; 2002; 2001(1):CD000369. PubMed ID: 11869573
[TBL] [Abstract][Full Text] [Related]
56. Beta-blockers for suspected or diagnosed acute myocardial infarction.
Safi S; Sethi NJ; Nielsen EE; Feinberg J; Jakobsen JC; Gluud C
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012484. PubMed ID: 31845756
[TBL] [Abstract][Full Text] [Related]
57. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
58. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.
Eke AC; Eleje GU; Eke UA; Xia Y; Liu J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008545. PubMed ID: 28188612
[TBL] [Abstract][Full Text] [Related]
59. Interferon for interferon naive patients with chronic hepatitis C.
Myers RP; Regimbeau C; Thevenot T; Leroy V; Mathurin P; Opolon P; Zarski JP; Poynard T
Cochrane Database Syst Rev; 2002; 2002(2):CD000370. PubMed ID: 12076394
[TBL] [Abstract][Full Text] [Related]
60. Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C.
Simin M; Brok J; Stimac D; Gluud C; Gluud LL
Aliment Pharmacol Ther; 2007 May; 25(10):1153-62. PubMed ID: 17451561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
